127 related articles for article (PubMed ID: 27156317)
1. Dual Specificity Phosphatase 6 (DUSP6) Polymorphism Predicts Prognosis of Inoperable Non-Small Cell Lung Cancer after Chemoradiotherapy.
Wang TL; Song YQ; Ren YW; Zhou BS; Wang HT; Bai L; Zhang HB; Yu H; Zhao YX
Clin Lab; 2016; 62(3):301-10. PubMed ID: 27156317
[TBL] [Abstract][Full Text] [Related]
2. Association of Topoisomerase II (TOP2A) and Dual-Specificity Phosphatase 6 (DUSP6) Single Nucleotide Polymorphisms with Radiation Treatment Response and Prognosis of Lung Cancer in Han Chinese.
Wang TL; Ren YW; Wang HT; Yu H; Zhao YX
Med Sci Monit; 2017 Feb; 23():984-993. PubMed ID: 28231233
[TBL] [Abstract][Full Text] [Related]
3. Dual-specificity phosphatase 6 genetic variants associated with risk of lung squamous cell carcinoma in Han Chinese.
Wang TL; Song YQ; Ren YW; Zhou BS; Wang HT; Gao Y; Yu H; Zhao YX
J Cancer Res Ther; 2018; 14(Supplement):S72-S78. PubMed ID: 29578153
[TBL] [Abstract][Full Text] [Related]
4. TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy.
Guan X; Liao Z; Ma H; Qian J; Liu Z; Yuan X; Gomez D; Komaki R; Wang LE; Wei Q
BMC Cancer; 2011 Oct; 11():447. PubMed ID: 21995493
[TBL] [Abstract][Full Text] [Related]
5. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.
Bi N; Yang M; Zhang L; Chen X; Ji W; Ou G; Lin D; Wang L
Clin Cancer Res; 2010 Apr; 16(8):2383-90. PubMed ID: 20332326
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
[TBL] [Abstract][Full Text] [Related]
9. Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy.
Guan X; Yin M; Wei Q; Zhao H; Liu Z; Wang LE; Yuan X; O'Reilly MS; Komaki R; Liao Z
BMC Cancer; 2010 Aug; 10():431. PubMed ID: 20712888
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer.
Díaz-García CV; Agudo-López A; Pérez C; Prieto-García E; Iglesias L; Ponce S; Rodríguez Garzotto A; Rodríguez-Peralto JL; Cortés-Funes H; López-Martín JA; Agulló-Ortuño MT
Tumour Biol; 2015 Feb; 36(2):1199-206. PubMed ID: 25344212
[TBL] [Abstract][Full Text] [Related]
11. Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment.
Käsmann L; Taugner J; Eze C; Roengvoraphoj O; Dantes M; Gennen K; Karin M; Petrukhnov O; Tufman A; Belka C; Manapov F
Anticancer Res; 2019 Sep; 39(9):5077-5081. PubMed ID: 31519618
[TBL] [Abstract][Full Text] [Related]
12. Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population.
Jin G; Miao R; Hu Z; Xu L; Huang X; Chen Y; Tian T; Wei Q; Boffetta P; Shen H
Int J Cancer; 2009 May; 124(9):2172-8. PubMed ID: 19132754
[TBL] [Abstract][Full Text] [Related]
13. Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy.
Butkiewicz D; Drosik A; Suwiński R; Krześniak M; Rusin M; Kosarewicz A; Rachtan J; Matuszczyk I; Gawkowska-Suwińska M
Int J Cancer; 2012 Oct; 131(7):E1100-8. PubMed ID: 22511383
[TBL] [Abstract][Full Text] [Related]
14. Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.
Zhang K; Tang S; Cao S; Hu L; Pan Y; Ma H; Guo X; Wu S; Shen H; Hu Z
Cancer Epidemiol; 2014 Aug; 38(4):414-8. PubMed ID: 24797335
[TBL] [Abstract][Full Text] [Related]
15. HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer.
Xu T; Wei Q; Lopez Guerra JL; Wang LE; Liu Z; Gomez D; O'Reilly M; Lin SH; Zhuang Y; Levy LB; Mohan R; Zhou H; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e229-35. PubMed ID: 22608953
[TBL] [Abstract][Full Text] [Related]
16. Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer.
Moncho-Amor V; Pintado-Berninches L; Ibañez de Cáceres I; Martín-Villar E; Quintanilla M; Chakravarty P; Cortes-Sempere M; Fernández-Varas B; Rodriguez-Antolín C; de Castro J; Sastre L; Perona R
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027181
[TBL] [Abstract][Full Text] [Related]
17. Effect of the BCL2 gene polymorphism on survival in advanced-stage non-small cell lung cancer patients who received chemotherapy.
Masago K; Togashi Y; Fujita S; Nagai H; Sakamori Y; Okuda C; Kim YH; Mishima M
Oncology; 2013; 84(4):214-8. PubMed ID: 23364242
[TBL] [Abstract][Full Text] [Related]
18. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH
Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175
[TBL] [Abstract][Full Text] [Related]
19. Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
Bergamino M; Rullan AJ; Saigí M; Peiró I; Montanya E; Palmero R; Ruffinelli JC; Navarro A; Arnaiz MD; Brao I; Aso S; Padrones S; Cardenal F; Nadal E
BMC Cancer; 2019 Feb; 19(1):165. PubMed ID: 30791870
[TBL] [Abstract][Full Text] [Related]
20. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
